Abstract: The present disclosure relates to a nitrogen-doped porous carbon material and a preparation method and use thereof. In the present disclosure, the preparation method of a nitrogen-doped porous carbon material includes the following steps: conducting carbonization on a biomass material to obtain a carbon source; and mixing the carbon source with a potassium 4-aminobenzoate aqueous solution, and drying and conducting calcination in a protective atmosphere sequentially to obtain the nitrogen-doped porous carbon material. In the preparation method, the potassium 4-aminobenzoate is used as a nitrogen source as well as an activator for preparing the nitrogen-doped porous carbon material. Nitrogen doping is simultaneously completed during the activation, and the nitrogen-doped porous carbon material can be prepared through one-step calcination.

Abstract: Various methods are provided for generating motion vectors in the context of 3D computer-generated images. An example method includes generating, for each pixel of one or more objects to be rendered in a current frame, a 1-phase motion vector (MV1) and a 0-phase motion vector (MV0), each MV1 and MV0 having an associated depth value, to thereby form an MV1 texture and an MV0 texture; converting the MV1 texture to a set of MV1 blocks and converting the MV0 texture to a set of MV0 blocks; and outputting the set of MV1 blocks and the set of MV0 blocks for image processing.

Abstract: Various methods are provided for the generation of motion vectors in the context of 3D computer-generated images. In one example, a method includes generating, for each pixel of one or more objects to be rendered in a current frame, a 1-phase motion vector (MV1) and a 0-phase motion vector (MV0), each MV1 and MV0 having an associated depth value, to thereby form an MV1 texture and an MV0 texture, each MV0 determined based on a camera MV0 and an object MV0, and outputting MV1 texture and the MV0 texture for image processing.

Abstract: Various methods and systems are provided for accelerated image rendering with motion compensation. In one embodiment, a method comprises calculating motion between a preceding image frame and a target image frame to be rendered, rendering a small image with a size smaller than a target size of the target image frame based on the calculated motion, and generating the target image frame at the target size based on the small image, the calculated motion, and a reference image frame. In this way, high-quality image frames for a video stream may be generated with a reduced amount of rendering for each frame, thereby reducing the overall processing resources dedicated to rendering as well as the power consumption for image rendering.

Abstract: Various methods are provided for the generation of motion vectors in the context of 3D computer-generated images. In one example, a method includes generating, for each pixel of one or more objects to be rendered in a current frame, a 1-phase motion vector (MV1) and a 0-phase motion vector (MV0), each MV1 and MV0 having an associated depth value, to thereby form an MV1 texture and an MV0 texture, each MV0 determined based on a camera MV0 and an object MV0, converting the MV1 texture to a set of MV1 pixel blocks and converting the MV0 texture to a set of MV0 pixel blocks and outputting the set of MV1 pixel blocks and the set of MV0 pixel blocks for image processing.

Abstract: Various methods are provided for the generation of motion vectors in the context of 3D computer-generated images. In one example, a method includes generating, for each pixel of one or more objects to be rendered in a current frame, a 1-phase motion vector (MV1) and a 0-phase motion vector (MV0), each MV1 and MV0 having an associated depth value, to thereby form an MV1 texture and an MV0 texture, each MV0 determined based on a camera MV0 and an object MV0, converting the MV1 texture to a set of MV1 pixel blocks and converting the MV0 texture to a set of MV0 pixel blocks and outputting the set of MV1 pixel blocks and the set of MV0 pixel blocks for image processing.

Abstract: Various methods are provided for generating motion vectors in the context of 3D computer-generated images. An example method includes generating, for each pixel of one or more objects to be rendered in a current frame, a 1-phase motion vector (MV1) and a 0-phase motion vector (MV0), each MV1 and MV0 having an associated depth value, to thereby form an MV1 texture and an MV0 texture; converting the MV1 texture to a set of MV1 blocks and converting the MV0 texture to a set of MV0 blocks; and outputting the set of MV1 blocks and the set of MV0 blocks for image processing.

Abstract: A donor construct and a gene knockout method, as well as a system and kit for the gene knockout are provided. The donor construct is a linear donor DNA or can be cleaved in a cell to produce the linear donor DNA. The gene knockout method uses a marker gene contained in the donor construct to enrich cells in which a gene is knocked out, thereby improving the efficiency of generating the gene knockout by a sequence-specific nuclease.

Abstract: Various methods and systems are provided for accelerated image rendering with motion compensation. In one embodiment, a method comprises calculating motion between a preceding image frame and a target image frame to be rendered, rendering a small image with a size smaller than a target size of the target image frame based on the calculated motion, and generating the target image frame at the target size based on the small image, the calculated motion, and a reference image frame. In this way, high-quality image frames for a video stream may be generated with a reduced amount of rendering for each frame, thereby reducing the overall processing resources dedicated to rendering as well as the power consumption for image rendering.

Abstract: A donor construct and a gene knockout method, as well as a system and kit for the gene knockout are provided. The donor construct is a linear donor DNA or can be cleaved in a cell to produce the linear donor DNA. The gene knockout method uses a marker gene contained in the donor construct to enrich cells in which a gene is knocked out, thereby improving the efficiency of generating the gene knockout by a sequence-specific nuclease.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: The present invention provides crosslinked amine polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritus, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.

Abstract: The present invention provides a crosslinked amine and amide polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritis, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: An apparatus for a crane comprises a large-cavity pressure sensor, a small-cavity pressure sensor, a controller, a telescopic oil cylinder, and a telescopic oil cylinder regulator. The large-cavity pressure sensor can measure the oil pressure in a large cavity of the telescopic oil cylinder. The small cavity pressure sensor can measure the oil pressure in a small cavity of the telescopic oil cylinder. The controller can control an output electrical signal according to a large-cavity oil pressure fed back by the large-cavity pressure sensor and a small-cavity oil pressure fed back by the small-cavity pressure sensor, and, by means of the electrical signal, control a change of the amount of hydraulic oil flowing into and out of the large cavity and the small cavity of the telescopic oil cylinder so as to regulate the oil pressures in the large cavity and the small cavity.

Abstract: The present disclosure relates to a pharmaceutical composition comprising: (a) ?-lactam antibiotics and (b) a metallo-?-lactamases (MBLs) inhibitor. The inhibitor relates to Bi(III) compounds or the pharmaceutically acceptable salts thereof. The present patent also provides methods of making Bi(III) compounds or the pharmaceutically acceptable salts thereof. Also provided is a method for treating MBLs-producing bacterial infection using a metal replacement mechanism.

Abstract: A refractive lens for displaying three-dimensional images (3D) comprises a first substrate, a second substrate, and a refractive layer configured between the first substrate and the second substrate and configured as a plurality of lens units of the refractive lens. The refractive lens is capable of being coupled to a first display panel having a pixel unit pitch A and a second display panel having a pixel unit pitch B to display the 3D images, the pixel unit pitch A being different from the pixel unit pitch B. Each lens unit of the refractive lens has an equal length p, and p is a common multiple of 2*A and 2*B. Each lens unit of the refractive lens is driven by a same driving voltage.

Abstract: The present invention provides crosslinked amine polymers effective for binding and removing bile salts from the gastrointestinal tract. These bile acid binding polymers or pharmaceutical compositions thereof can be administered to subjects to treat various conditions, including hypercholesteremia, diabetes, pruritus, irritable bowel syndrome-diarrhea (IBS-D), bile acid malabsorption, and the like.

Abstract: The present disclosure provides a refractive lens for displaying 3D images and capable of being coupled to a plurality of display panels having different pixel unit pitches, including at least a first display panel having a pixel unit pitch A and a second display panel having a pixel unit pitch B. The refractive lens includes a first substrate, a second substrate, and a refractive layer configured between the first substrate and the second substrate and configured as a plurality of lens units based on the different pixel unit pitches. Each lens unit has equal length of a common multiple of at least 2A and 2B. Each lens unit is driven by same driving voltages.